Related Experiment Video
Updated: May 15, 2026
10:04
Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
Published on: September 5, 2017
Advances in tuberculosis 2011-2012.
Heather J Zar1, Zarir F Udwadia
1Department of Paediatrics and Child Health, Red Cross War Memorial Children's Hospital, University of Cape Town, Cape Town, South Africa. heather.zar@uct.ac.za
Thorax
|January 17, 2013
Summary
Global interest in tuberculosis (TB) research is rising, driving advances in diagnostics and treatments for drug-resistant forms. Further research is crucial for better vaccines and shorter regimens to combat TB effectively.
Area of Science:
- * Infectious Diseases
- * Public Health
- * Medical Research
Background:
- * Renewed global focus and funding have accelerated tuberculosis (TB) research and publications.
- * Rising incidence of drug-resistant TB, including multidrug-resistant (MDR) and extensively drug-resistant (XDR) strains, necessitates improved diagnostics and treatments.
- * The co-epidemics of HIV and TB underscore the need for enhanced preventive and treatment strategies.
Purpose of the Study:
- * To review recent advances in adult and childhood tuberculosis research.
- * To highlight ongoing research priorities and the need for operational research.
- * To emphasize the development of novel diagnostics, therapeutics, and vaccines for TB.
Main Methods:
- * Review of recent scientific literature and clinical trial data on tuberculosis.
- * Analysis of progress in diagnostic techniques, therapeutic agents, and preventive strategies.
- * Identification of key research gaps and future directions in TB control.
Main Results:
- * Significant validation of molecular diagnostic techniques in adult TB.
- * Advances in therapeutic strategies, including drug trials for existing and novel agents.
- * Increased understanding of the paediatric TB burden and progress in preventive measures.
Conclusions:
- * Despite advances, critical research priorities remain, including improved diagnostics, biomarkers, and shorter treatment regimens.
- * Development of a safe and effective TB vaccine is a key future goal.
- * Operational research is essential for translating research findings into widespread clinical practice and optimal patient benefit.
Related Concept Videos
01:26Pulmonary Tuberculosis IV
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
01:31Pulmonary Tuberculosis III
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
01:28Pulmonary Tuberculosis V
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
01:28Pulmonary Tuberculosis II
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
01:29Pulmonary Tuberculosis I
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
01:25Transmission-based Precautions II: Airborne and Protective Environment
Transmission-based precautions are for patients infected or suspected to be infected (or colonized) with organisms posing a significant risk to others. The transmission precautions include airborne and protective environment precautions.
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...